To evaluate the therapeutic synergy between ferroptosis induction and AGR2 ablation, we conducted assessments of IKE—a metabolically stabilized derivative of the ferroptosis inducer erastin—in orthotopic pancreatic cancer models. This evidence concerns the gene AGR2 and familial pancreatic carcinoma.